Abstract
Population aging in Brazil has driven an increase in the prevalence of neurodegenerative diseases, such as Parkinson's Disease (PD). The treatment of PD is based on dopamine replacement, with levodopa being the most used drug. However, its oral administration presents challenges, including swallowing difficulties in elderly patients and low bioavailability due to first-pass metabolism and…